Literature DB >> 12169441

Ubiquitin-conjugating enzyme E214k/HR6B is dispensable for increased protein catabolism in muscle of fasted mice.

Olasunkanmi A J Adegoke1, Nathalie Bédard, Henk P Roest, Simon S Wing.   

Abstract

Activated skeletal muscle proteolysis in catabolic states has been linked to an upregulation of the ATP-ubiquitin-dependent proteolytic system. Previous studies suggested that the N-end rule pathway is primarily responsible for the bulk of skeletal muscle proteolysis. The activity of this pathway is dependent on the 14-kDa ubiquitin-conjugating enzyme E2(14k) (HR6B) and the ubiquitin protein ligase Ubr1. To address the requirement of E2(14k) in muscle proteolysis, we examined muscle protein metabolism in wild-type (WT) mice and mice lacking the E2(14k) gene (KO) in fed and fasted (48 h) states. Baseline body weight, muscle mass, and protein content were similar, and these parameters decreased similarly upon fasting in the two genotypes. There were also no effects of genotype on the rate of proteolysis in soleus muscle. The fasting-induced increase in the amount of ubiquitinated proteins was the same in WT and KO mice. The absence of any significant effect of loss of E2(14k) function was not due to a compensatory induction of the closely related isoform HR6A. Total intracellular concentration of E2(14k) and HR6A in the WT mice was 290 +/- 40 nM, but the level in the KO mice (reflecting the level of HR6A) was 110 +/- 9 nM. This value is about threefold the apparent Michaelis-Menten constant (K(m)) of E2(14k) (approximately 40 nM) for stimulating conjugation in muscle extracts. Because the HR6A isoform has a K(m) of 16 nM for stimulating conjugation, the HR6A levels in the muscles of KO mice appear sufficient for supporting conjugation mediated by this pathway during fasting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169441     DOI: 10.1152/ajpendo.00097.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  Tissue distribution of the "N-end rule" ubiquitin-conjugating enzyme, HR6, in the rat.

Authors:  Andre Tomasino; Lars Klimaschewski
Journal:  Histochem Cell Biol       Date:  2005-05-03       Impact factor: 4.304

2.  Regulation of posttranscriptional modification as a possible therapeutic approach for retinal neuroprotection.

Authors:  Yoko Ozawa; Toshihide Kurihara; Kazuo Tsubota; Hideyuki Okano
Journal:  J Ophthalmol       Date:  2010-11-07       Impact factor: 1.909

Review 3.  Deubiquitinases in skeletal muscle atrophy.

Authors:  Simon S Wing
Journal:  Int J Biochem Cell Biol       Date:  2013-05-13       Impact factor: 5.085

4.  Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia.

Authors:  J Khal; S M Wyke; S T Russell; A V Hine; M J Tisdale
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

Review 5.  Role of E2-Ub-conjugating enzymes during skeletal muscle atrophy.

Authors:  Cecile Polge; Didier Attaix; Daniel Taillandier
Journal:  Front Physiol       Date:  2015-03-10       Impact factor: 4.566

6.  UBE2B is implicated in myofibrillar protein loss in catabolic C2C12 myotubes.

Authors:  Cécile Polge; Roza Leulmi; Marianne Jarzaguet; Agnes Claustre; Lydie Combaret; Daniel Béchet; Anne-Elisabeth Heng; Didier Attaix; Daniel Taillandier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-19       Impact factor: 12.910

7.  Monitoring post mortem changes in porcine muscle through 2-D DIGE proteome analysis of Longissimus muscle exudate.

Authors:  Alessio Di Luca; Giuliano Elia; Anne Maria Mullen; Ruth M Hamill
Journal:  Proteome Sci       Date:  2013-03-20       Impact factor: 2.480

Review 8.  Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.

Authors:  David Nury; Christine Doucet; Olivier Coux
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

9.  Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation.

Authors:  Yoko Ozawa; Keiko Nakao; Toshihide Kurihara; Takuya Shimazaki; Shigeto Shimmura; Susumu Ishida; Akihiko Yoshimura; Kazuo Tsubota; Hideyuki Okano
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

10.  Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.

Authors:  A S Whitehouse; J Khal; M J Tisdale
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.